US EditionDengue Vaccine: How Butanan’s Immune Agent Works
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The National Sanitary Supervisory Agency (Anvisia) finalized the technical evaluation of Butan-DV, the first single dose vaccine against dengue in the world, and initiated the administrative stage to approve the registration. On Thursday, 26th, the signatory agency, in São Paulo, signed the Terms of Commitment with the Bhutan Institute, the last step before publication in the Official Journal of the Union. + Read more about Health in the West Th…
The dengue vaccine developed by the Institute of Butantan, Butan-DV, can protect against the four existing types of dengue virus: called DENV-1, DENV-2, DENV-3 and DENV-4. Dengue vaccine: Advise the final term signature with Butantan for the registration of the immuniser 'Ganhei more energy': says Henrique Focusa on 'the diet of the forest' that lost him in 17 kilos in 3 months The complete results of the clinical study with the immunizer were p…
Returned to the population from 12 to 59 years old, immunization will be offered from 2026
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
